20904 ⎘
Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof; Peptides having 12 to 20 amino acids Bombesin; Related peptides
METHODS AND COMPOSITIONS FOR INDUCING DIFFERENTIATION OF HUMAN BROWN ADIPOCYTE PROGENITORS
#2LYOPHILIZED PREPARATION OF CYTOTOXIC DIPEPTIDES
#3Targeting modules for universal chimeric antigen receptor expressing immune cells and use in the treatment of cancer, infections and autoimmune disorders
#4METHODS AND COMPOSITIONS FOR INDUCING DIFFERENTIATION OF HUMAN BROWN ADIPOCYTE PROGENITORS
#5Lyophilized preparation of cytotoxic dipeptides
#6METHODS OF REDUCING TYPE 2 CYTOKINE-MEDIATED INFLAMMATION USING NEUROMEDIN PEPTIDES
#7Lyophilized preparation of cytotoxic dipeptides
#8Targeting modules for universal chimeric antigen receptor expressing immune cells and use in the treatment of cancer infections and autoimmune disorders
#9Lyophilized preparation of cytotoxic dipeptides
#10Methods for the treatment of cancer metastasis
#11ITCH TREATMENT USING A COMBINATION OF NEUROKININ-1, GASTRIN RELEASING PEPTIDE, AND GLUTAMATE RECEPTOR ANTAGONISTS
#12SOLVENT/POLYMER SOLUTIONS AS SUSPENSION VEHICLES
#13COMPOSITIONS AND METHODS THAT TARGET REGULATION OF BREATHING
#14Methods and compositions for inducing differentiation of human brown adipocyte progenitors
#15Designer circuit controlling diet-induced obesity
#16NEW ITCH TREATMENT USING A COMBINATION OF NEUROKININ-1, GASTRIN RELEASING PEPTIDE, AND GLUTAMATE RECEPTOR ANTAGONISTS
#17Solvent/polymer solutions as suspension vehicles
#18Compositions and methods for treating pruritus
#19Solvent/polymer solutions as suspension vehicles
#20Solvent/polymer solutions as suspension vehicles
#21Solvent/polymer solutions as suspension vehicles
#22Solvent/polymer solutions as suspension vehicles
#23Osmotic drug delivery devices containing suspension formulations comprising particles having active agents and nonaqueous single-phase vehicles
#24Compositions and methods for treating pruritus
#25SOLVENT/POLYMER SOLUTIONS AS SUSPENSION VEHICLES
#26Metallopeptide gamma-Melanocyte Stimulating Hormone Compounds
#27Alzheimer's disease-specific alterations of the ERK1/ERK2 Phosphorylation ratio-Alzheimer's disease-specific molecular biomarkers (ADSMB)
#28Solvent/polymer solutions as suspension vehicles
#29Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder
#30Process for the production of implants
#31Metallopeptide compounds
#32Lactone bearing absorbable polymers